Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TCF-1 regulates HIV-specific CD8+ T cell expansion capacity
Rachel L. Rutishauser, … , Joseph M. McCune, Peter W. Hunt
Rachel L. Rutishauser, … , Joseph M. McCune, Peter W. Hunt
Published December 22, 2020
Citation Information: JCI Insight. 2021;6(3):e136648. https://doi.org/10.1172/jci.insight.136648.
View: Text | PDF
Research Article AIDS/HIV Immunology

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity

  • Text
  • PDF
Abstract

Although many HIV cure strategies seek to expand HIV-specific CD8+ T cells to control the virus, all are likely to fail if cellular exhaustion is not prevented. A loss in stem-like memory properties (i.e., the ability to proliferate and generate secondary effector cells) is a key feature of exhaustion; little is known, however, about how these properties are regulated in human virus–specific CD8+ T cells. We found that virus-specific CD8+ T cells from humans and nonhuman primates naturally controlling HIV/SIV infection express more of the transcription factor TCF-1 than noncontrollers. HIV-specific CD8+ T cell TCF-1 expression correlated with memory marker expression and expansion capacity and declined with antigenic stimulation. CRISPR-Cas9 editing of TCF-1 in human primary T cells demonstrated a direct role in regulating expansion capacity. Collectively, these data suggest that TCF-1 contributes to the regulation of the stem-like memory property of secondary expansion capacity of HIV-specific CD8+ T cells, and they provide a rationale for exploring the enhancement of this pathway in T cell–based therapeutic strategies for HIV.

Authors

Rachel L. Rutishauser, Christian Deo T. Deguit, Joseph Hiatt, Franziska Blaeschke, Theodore L. Roth, Lynn Wang, Kyle A. Raymond, Carly E. Starke, Joseph C. Mudd, Wenxuan Chen, Carolyn Smullin, Rodrigo Matus-Nicodemos, Rebecca Hoh, Melissa Krone, Frederick M. Hecht, Christopher D. Pilcher, Jeffrey N. Martin, Richard A. Koup, Daniel C. Douek, Jason M. Brenchley, Rafick-Pierre Sékaly, Satish K. Pillai, Alexander Marson, Steven G. Deeks, Joseph M. McCune, Peter W. Hunt

×

Figure 5

TCF-1 KO impairs human CD8+ T cell proliferation.

Options: View larger image (or click on image) Download as PowerPoint
TCF-1 KO impairs human CD8+ T cell proliferation.
(A) Correlation betwee...
(A) Correlation between TCF-1 expression in HIV-specific CD8+ T cells and the proportion that divide after 6-day in vitro peptide stimulation. (B) Correlation between TCF-1 expression in CMV-specific CD8+ T cells and their expansion after 6-day in vitro peptide stimulation (fold change [FC] in the frequency of CMV-specific CD8+ T cells [gated on total CD8+ T cells], stimulated versus unstimulated cells; n = 14). (C) CRISPR-Cas9–mediated deletion of TCF7 (Scr, scrambled guide RNA [gRNA]; RNP, ribonucleoprotein; n = 13 biological replicates). (D) TCF-1 protein downregulation in CD8+ T cells after TCF7 KO (red) compared with electroporation with Scr gRNA (gray). (E) CD8+ T cell phenotype after TCF7 KO. (F) Proportion of divided CD8+ T cells (%CTVlo) after 5-day stimulation with αCD3/CD28. (G) Correlation between the reduction in TCF-1 expression (MFI) and the reduction of CD8+ T cell proliferation (%CTVlo after stimulation). Spearman’s correlation (A, B, and G) and Wilcoxon’s signed-rank (D–F).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts